RespiriNTM

Progress novel assets (one FIH start) for non-tubercular mycobacteria that may act synergistically with bedaquiline and cytochrome bc drugs

keywords: IMI projects Antimicrobial resistance Infectious diseases AMR Accelerator Conducting clinical trials Target identification